Change 5-day change 1-year change 3-year change Capi.($)
-1.37%+8.90%+91.28%+130.00% 1,098B
-0.77%+1.91%+49.46%+49.44% 631B
+0.85%+2.58%+25.90%+64.34% 438B
-1.13%+3.62%+49.72%+38.22% 368B
-0.74%+1.09%+33.81%+38.95% 298B
-1.22%+2.99%+8.44%+6.11% 251B
-0.70%+6.23%+45.32%+57.82% 226B
+0.34%+1.62%-4.91%-50.77% 209B
+2.04%+0.38%+12.70%+69.71% 165B
Average -0.30%+1,662.58%+34.64%+44.87% 409.37B
Weighted average by Cap. -0.63%+1,339.54%+50.10%+66.03%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-